生物
癌症研究
细胞外
中性粒细胞胞外陷阱
三阴性乳腺癌
免疫学
细胞因子
乳腺癌
癌症
细胞生物学
炎症
遗传学
作者
Tarek Taifour,Sherif Samer Attalla,Dongmei Zuo,Yu Gu,Virginie Sanguin‐Gendreau,Hailey Proud,Emilie Solymoss,Tung Bui,Hellen Kuasne,Vasilios Papavasiliou,Chun Geun Lee,Suchitra Kamle,Peter M. Siegel,Jack A. Elias,Morag Park,William J. Muller
出处
期刊:Immunity
[Cell Press]
日期:2023-11-30
卷期号:56 (12): 2755-2772.e8
被引量:35
标识
DOI:10.1016/j.immuni.2023.11.002
摘要
In triple-negative breast cancer (TNBC), stromal restriction of CD8+ T cells associates with poor clinical outcomes and lack of responsiveness to immune-checkpoint blockade (ICB). To identify mediators of T cell stromal restriction, we profiled murine breast tumors lacking the transcription factor Stat3, which is commonly hyperactive in breast cancers and promotes an immunosuppressive tumor microenvironment. Expression of the cytokine Chi3l1 was decreased in Stat3−/− tumors. CHI3L1 expression was elevated in human TNBCs and other solid tumors exhibiting T cell stromal restriction. Chi3l1 ablation in the polyoma virus middle T (PyMT) breast cancer model generated an anti-tumor immune response and delayed mammary tumor onset. These effects were associated with increased T cell tumor infiltration and improved response to ICB. Mechanistically, Chi3l1 promoted neutrophil recruitment and neutrophil extracellular trap formation, which blocked T cell infiltration. Our findings provide insight into the mechanism underlying stromal restriction of CD8+ T cells and suggest that targeting Chi3l1 may promote anti-tumor immunity in various tumor types.
科研通智能强力驱动
Strongly Powered by AbleSci AI